AmgenFRA:AMG +2.06%86 Days Inventory is 205.04 as of Mar. 2026, which is 15% below its 10-year median of 242.33. GuruFocus rates FRA:AMG with a GF Score™ of 86/100 and a GF Value™ of €302.42 (Fairly Valued). The stock has 9 warning signs investors should review. Among 918 Drug Manufacturers companies, Amgen ranks worse than 63.62% on this metric.
Days Inventory is also known as Days Sales of Inventory (DSI). Amgen's Average Total Inventories for the
three
months ended in Mar. 2026 was €5,334 Mil. Amgen's Cost of Goods Sold for the
three
months ended in Mar. 2026 was €2,374 Mil.
Hence, Amgen's Days Inventory for the
three
months ended in Mar. 2026 was 205.04.
The historical rank and industry rank for Amgen's Days Inventory or its related term are showing as below:
FRA:AMG'
s Days Inventory Range Over the Past 10 Years
Min: 198.17 Med: 242.33 Max: 312.01
Current: 198.17
During the past 13 years, Amgen's highest Days Inventory was 312.01. The lowest was 198.17. And the median was 242.33.
FRA:AMG's Days Inventory is ranked worse than 63.62% of 918
companies
in the Drug Manufacturers industry
Industry Median: 164.43
vs FRA:AMG: 198.17
Amgen's Days Inventory
declined
from Mar. 2025 (214.50) to Mar. 2026 (205.04).
Inventory Turnover measures how fast the company turns over its inventory within a year.
Amgen's Inventory Turnover for the
three
months ended in Mar. 2026 was 0.45.
Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.
Amgen's Inventory-to-Revenue for the
three
months ended in Mar. 2026 was 0.72.
Amgen (FRA:AMG) Days Inventory Explanation
Days Inventory indicates the liquidity of the inventory. Generally, a lower Days Inventory is preferred as it indicates a shorter duration to clear off the inventory. An increase of the ratio may indicate the company's sales slowed. Similar ratios related to Days Inventory are:
1. Inventory Turnover measures how fast the company turns over its inventory within a year.
Amgen's Inventory Turnover for the
three
months ended in Mar. 2026 is calculated as
2. Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.
Amgen's Inventory to Revenue for the
three
months ended in Mar. 2026 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Be Aware
A lot of business are seasonable. It makes more sense to compare Days Inventory from the same period in the previous year instead of from the previous quarter.
Amgen Days Inventory Related Terms
Amgen Days Inventory Historical Data
* Premium members only.
The historical data trend for Amgen's Days Inventory can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
FRA:AMG vs GILD, PFE, BMY: Days Inventory Comparison
For the Drug Manufacturers - General subindustry, Amgen's Days Inventory, along with its competitors' market caps and Days Inventory data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Amgen Days Inventory vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Amgen's Days Inventory distribution charts can be found below:
* The bar in red indicates where Amgen's Days Inventory falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Amgen (FRA:AMG) has a Days Inventory of 205.04 as of Mar. 2026. Days inventory represents the average amount of days a company holds inventory before selling it. View historical data on Amgen and its competitors. This is 15% below median its historical median of 242.33. Over the past decade, Amgen's Days Inventory has ranged from 198.17 to 312.01. According to the industry distribution chart, Amgen ranks #584 out of 918 companies in the Drug Manufacturers industry, placing it in the top 63.6%.
Is Amgen's Days Inventory too high?
Amgen's current Days Inventory of 205.04 is 15% below median its 10-year median of 242.33. Over the past 10 years, this metric has ranged from a low of 198.17 to a high of 312.01. The Drug Manufacturers industry median Days Inventory is 164.43. Amgen's value of 205.04 is 24.7% above this industry median. Based on the distribution chart, Amgen ranks #584 out of 918 companies in the Drug Manufacturers industry, which is below the industry midpoint. Overall, Amgen has a GF Score™ of 86/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Amgen's Days Inventory compare to GILD and PFE?
According to the Drug Manufacturers industry distribution chart, Amgen ranks #584 out of 918 companies for Days Inventory. This places Amgen in the lower half of its industry. The industry median Days Inventory is 164.43. Amgen's value of 205.04 is 24.7% above this benchmark. Historically, Amgen's own Days Inventory has ranged from 198.17 to 312.01 over the past decade. While the company's 10-year median is 242.33 vs. the industry median of 164.43, Amgen has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Days Inventory for a Drug Manufacturers company?
The median Days Inventory among Drug Manufacturers companies is 164.43, based on 918 companies in the industry. Companies in the top quartile (top 25%) have a Days Inventory significantly above this median, while those in the bottom quartile fall well below. However, Days Inventory should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Amgen's current Days Inventory of 205.04 is 24.7% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Days Inventory mean?
A high Days Inventory can signal that a stock is expensive relative to its fundamentals. Days inventory represents the average amount of days a company holds inventory before selling it. View historical data on Amgen and its competitors. For the Drug Manufacturers industry, the median Days Inventory is 164.43 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Amgen's current Days Inventory is 205.04, which is 15% below median its own 10-year median of 242.33. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Amgen stock overvalued right now?
Based on GuruFocus' analysis, Amgen (FRA:AMG) is currently considered Fairly Valued. The stock's GF Value™ is €302.42, compared to a current price of €320.00 — trading 5.8% above its estimated fair value. The current Days Inventory is 205.04, which is 15% below median its 10-year median of 242.33 and 24.7% above the Drug Manufacturers industry median of 164.43. Amgen's overall GF Score™ is 86/100 with 9 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Days Inventory calculated?
Days Inventory is calculated from a company's financial statements. For Amgen (FRA:AMG), the current Days Inventory is 205.04 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Amgen (FRA:AMG) Overvalued in 2026?
Based on GuruFocus' analysis, Amgen stock appears to be overvalued.
The current stock price of €320.00 is trading 5.8% above its estimated GF Value™ of €302.42.
GuruFocus considers Amgen to be Fairly Valued.
Key valuation signals for FRA:AMG:
Days Inventory: 205.04 (15% below median its 10-year median of 242.33)
GF Value™: €302.42 vs. price of €320.00 (5.8% above fair value)
Industry Position: 24.7% above the Drug Manufacturers median (#584 of 918)
No single metric tells the full story. See the FRA:AMG stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Amgen is a leader in biotechnology-based human therapeutics. Flagship drugs include red blood cell boosters Epogen and Aranesp, immune system boosters Neupogen and Neulasta, and Enbrel and Otezla for inflammatory diseases. Amgen introduced its first cancer therapeutic, Vectibix, in 2006 and markets bone-strengthening drugs Prolia/Xgeva (approved 2010) and Evenity (2019). The acquisition of Onyx Pharmaceuticals bolstered the firm's therapeutic oncology portfolio with Kyprolis. Recent launches include Repatha (cholesterol-lowering), Aimovig (migraine), Lumakras (lung cancer), and Tezspire (asthma). The 2023 Horizon acquisition brought several rare-disease drugs, including thyroid eye disease drug Tepezza. Amgen also has a growing biosimilar portfolio.
86GF Score
Get the complete analysis for FRA:AMG
Days Inventory is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
FRA:AMG has been successfully added to your 
